Form 4 Tracker
Jonathan I Lieber

Chief Financial Officer; Director · 4 filings · Latest: Oct 9, 2026

Decoy Therapeutics Inc.
Rallybio Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RLYB
Jonathan I LieberChief Financial OfficerOct 9, 2026
Option Exercise
$6.083,910$23.8K13,650
RLYB
Jonathan I LieberChief Financial OfficerSep 29, 2026
Option Exercise
$6.085,000$30.4K9,740
RLYB
Jonathan I LieberChief Financial OfficerFeb 23, 2026
Sale
$5.06789$4.0K4,115